Santa Ana, CA – According to filings with the U.S. Securities and Exchange Commission, Aqua Medical is raising $8,350,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Lloyd Mencinger played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Aqua Medical

Aqua Medical has developed a disruptive, vapor-based, endoscopic, ablation technology to treat gastrointestinal disease and prevent GI cancers. Aqua Medical’s unique ablation technology consists of high temperature water vapor created by a radio frequency generator & delivered endoscopically through proprietary catheters to the GI tract.

To learn more about Aqua Medical, visit http://www.aquaendoscopy.com/

Contact:
Lloyd Mencinger, President and Chief Executive Officer
949-329-5306
https://www.linkedin.com/in/lloyd-mencinger-b588673/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved